Drug Store News - Teva gains two approvals
Related Results
Four strengths of doxazosin approvedTeva, Apotex gain approval for doxazosinDoxazosin helps fight metabolic syndromeIvax receives tentative approval for doxazosin mesylate tabletsFinasteride and doxazosin combo halts BPH progress in 67%
> Teva gained FDA approval for doxazosin tablets in base strengths of 1 mg, 2 mg, 4 mg and 8 mg. The alpha blocker is used in the treatment of benign prostatic hyperplasia and also hypertension. The company also received approval for bisoprolol fumarate and hydrochlorothiazide, 2.5 mg/6.25 mg, 5 mg/6.25 mg and 10 mg/6.25 mg tablets, a combination beta blocker and diuretic for treatment of hypertension.
COPYRIGHT 2001 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2008 Gale, Cengage Learning
